“A Revolutionary Treatment for COVID-19”
By Dr. Ernest Schapiro
This video concerns a very promising treatment for the till now often fatal, inflammatory phase of COVID, itself a form of sepsis, often accompanied by septic shock and the acute respiratory distress syndrome. It grew out of a successful treatment for sepsis and septic shock developed by Dr. Paul Marik, a critical care specialist at Eastern Virginia Medical School in 2015. It was originally called HAT for hydrocortisone, ascorbic acid, and thiamine.
The treatment is now being applied to COVID, which becomes a form of sepsis in COVID’s inflammatory second phase, under the name MATH+. M is for methyl prednisolone, a corticosteroid which has been found superior to hydrocortisone for lung inflammation. H is for heparin, an anticoagulant, because the severe inflammation of COVID activates the clotting system. The plus (+) is for possible ancillary measures such as melatonin, zinc, or vitamin D.
A group of physicians, of which Dr. Berkowitz is part, are finding this treatment very beneficial, and are working together to gain acceptance by the medical profession through their website and public appearances and soon to appear publications on COVID. The video addresses the controversy around use of corticosteroids in an infectious disease. The cellular physiology underlying the role of corticosteroids, vitamin C, and thiamine are discussed and in particular the remarkable synergy of corticosteroids and vitamin C at the cellular level is considered.
The cellular physiology constitutes an important rationale taken in conjunction with the clinical results. Vitamin C is an integral part of the vertebrate antistress system, yet humans lost their capability to produce vitamin C through an evolutionary error. The treatment of a very common and highly lethal disease with vitamins and hormones represents a new paradigm for medicine with far reaching implications, one which is provoking resistance in medical institutions .
For more on MATH+, see the website: https://covid19criticalcare.com/ The website includes medical reports of the treatment’s use, and other interviews and publications. One recent article published in the July 17, 2020 issue of The Telegraph, is significantly entitled “Why coronavirus deaths remain low in the US despite surge in new cases — with the subtitle: “Advances in a number of treatments appears to have contained the death rate as records continue to be broken for new infections.” See the article linked here. The article discusses the use of the MATH+ approach in the current outbreak of COVID in Houston, TX — a topic which has been covered in articles from the LA Times, to the London Telegraph.